Stock listing

Stockholm:SPRINT Sprint Bioscience AB Aktie

Home listing (Stockholm) of Sprint Bioscience AB

Follow Sprint Bioscience AB into a list and get an email when it puts out news.

Share price · OMXSTO:SPRINT

3.68 SEK -0.24 (-6.1%)

Close on Nov 20, 2026

Past year +475.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
3.57 – 3.95 SEKNov 20, 2026
Volume
195,798 sharesNov 20, 2026
Market cap
388.3M SEKAt the close on Nov 20, 2026 · price × 105.5M shares outstanding
52-week range
0.578 – 4.59 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
1.01M SEKMedian day 242,497 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Sprint Bioscience AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:SPRINT · Home3.68 SEK-0.24 (-6.1%)195,7983.953.953.573.92Close on Nov 20, 2026
Munich:5JA1€0.351 EUR0.000 (0.0%)—€0.351€0.351€0.351€0.351Close on Nov 20, 2026
Frankfurt:5JA1€0.307 EUR-0.024 (-7.3%)—€0.319€0.319€0.307€0.331Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:SPRINT · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
3.68-0.24-6.1%3.953.953.57195,798
3.92-0.03-0.8%3.943.943.83112,754
3.95-0.04-1.0%3.933.993.83243,484
3.99+0.12+3.1%3.794.003.78415,201
3.87+0.09+2.4%3.843.953.75566,278
3.78-0.25-6.2%4.034.093.73491,273
4.03+0.03+0.8%3.834.103.72654,434
4.00+0.35+9.6%3.644.003.55470,334
3.65+0.16+4.6%3.433.693.39347,906
3.49+0.06+1.7%3.413.523.40106,291
3.43+0.07+2.1%3.383.583.32330,296
3.36-0.24-6.7%3.583.633.36379,140
3.60+0.10+2.9%3.633.633.5116,849
3.50+0.06+1.7%3.413.703.41290,890
3.44+0.03+0.9%3.423.513.4185,768
3.41-0.04-1.2%3.453.453.33102,608
3.45+0.11+3.3%3.283.463.28227,690
3.34-0.01-0.3%3.353.393.2549,508
3.35-0.25-6.9%3.573.573.25445,818
3.60+0.14+4.0%3.523.633.5061,451
3.46-0.08-2.3%3.473.623.4641,370
3.54-0.01-0.3%3.523.623.43303,932
3.55-0.06-1.7%3.533.733.53119,371
3.61-0.22-5.7%3.753.763.52228,072
3.83+0.01+0.3%3.823.883.7157,904
3.82+0.07+1.9%3.723.883.67341,205
3.75+0.10+2.7%3.633.803.62223,947
3.65+0.01+0.3%3.593.723.56392,328
3.64+0.15+4.3%3.483.663.35429,220
3.49+0.03+0.9%3.463.623.37188,324
3.46-0.12-3.4%3.573.673.46123,177
3.58+0.05+1.4%3.563.653.40207,045
3.53-0.04-1.1%3.463.573.40163,366
3.57+0.17+5.0%3.413.573.40577,486
3.40+0.10+3.0%3.323.453.25447,904
3.30+0.18+5.8%3.093.333.09574,593
3.12+0.07+2.3%3.003.202.96141,219
3.05+0.27+9.7%2.803.172.79241,509
2.78+0.01+0.4%2.712.792.6582,859
2.77-0.08-2.8%2.802.862.55115,101
2.85-0.01-0.3%2.862.862.7689,436
2.86-0.09-3.1%2.952.982.8190,099
2.950.000.0%2.952.962.79302,696
2.95+0.05+1.7%2.842.962.75363,948
2.90+0.12+4.3%2.802.952.72372,499
2.78+0.04+1.5%2.742.822.7183,496
2.740.000.0%2.692.842.64153,490
2.740.000.0%2.722.742.551,252,178
2.74-0.14-4.9%2.913.002.68799,244
2.88-0.31-9.7%3.133.142.84891,948
3.19-0.05-1.5%3.203.203.1355,563
3.24-0.01-0.3%3.263.273.13127,187
3.25-0.04-1.2%3.253.263.13173,438
3.29+0.01+0.3%3.223.353.22110,005
3.28-0.02-0.6%3.303.383.19312,923
3.30+0.10+3.1%3.123.303.10268,442
3.20+0.02+0.6%3.123.283.10178,120
3.18-0.11-3.3%3.223.283.08343,872
3.29+0.08+2.5%3.163.333.10365,085
3.21+0.06+1.9%3.003.232.98313,756
3.150.000.0%3.163.173.00113,979
3.15-0.02-0.6%3.173.213.00375,413
3.17+0.16+5.3%3.083.182.98344,519
3.01-0.28-8.5%3.263.362.771,367,233

Splits

3 splits since 2021 · OMXSTO:SPRINT · every price before a split is adjusted for it

DayRatioWhat
60-for-59Split
47-for-40Split
21-for-20Split
Ticker
Stockholm:SPRINT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

All Sprint Bioscience AB news

Sprint Bioscience AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 6 in all · newest Nov 9, 2026 · oldest 2025
Decks
1 deck · latest Apr 24, 2025

Where Sprint Bioscience AB is listed

ListingExchangeCountryCurrency
Stockholm:SPRINT · Home listing · This pageStockholmSwedenSEK
gettex:5JA1gettexGermanyEUR
LS Exchange:A14NY2LS ExchangeGermanyEUR
Lang & Schwarz:A14NY2Lang & SchwarzGermanyEUR
Munich:5JA1MunichGermanyEUR
Frankfurt:5JA1FrankfurtGermanyEUR
Stuttgart:5JA1StuttgartGermanyEUR

Valuation

EV/sales 2.1× against a median of 33.8×: 2nd lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
295.0M SEK
P/E
5.1×
EV/sales
2.1×
EV/EBITDA
3.7×
Price/book
4.3×
Gross margin
78.0%
Operating margin
56.2%
Net margin
54.4%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Sprint Bioscience AB · OMXSTO:SPRINTUS$37.98MUS$28.86M5.1×2.1×3.7×4.3×54.4%0.0×n/a
Herantis Pharma PLC · OMXHEX:HRTISUS$38.69MUS$38.62Mn/an/an/an/an/an/an/a
Harvard Apparatus Regenerative Technology Inc · OTC:HRGNUS$38.54MUS$36.69Mn/a36.5×n/a73.8×−642.0%0.0×0.09
Quratis Inc. · KRX:348080US$38.36MUS$29.47Mn/a36.2×n/a1.1×n/a0.0×n/a
OSE Immunotherapeutics SA · EURONEXT:OSEUS$38.31MUS$52.28Mn/a18.2×n/a1.3×n/a1.3×n/a
KoBioLabs, Inc. · KRX:348150US$38.23MUS$6.96Mn/a0.1×n/a1.8×−6.4%0.2×n/a
Theralase Technologies Inc. · TSXV:TLTUS$37.89MUS$34.22Mn/a61.1×n/a7.9×−472.5%0.0×0.75
Connect Biopharma Holdings Limited · NASDAQ:CNTBUS$37.15MUS$18.16Mn/a4.9×n/a3.1×n/a0.0×0.93
Coiled Therapeutics PLC · LSE:COILUS$37.13MUS$30.46Mn/an/an/a0.6×n/a0.0×n/a
TaiRx, Inc. · TPEX:6580US$37.08MUS$28.62Mn/a33.8×n/a3.3×−793.3%0.0×n/a
Pliant Therapeutics, Inc. · NASDAQ:PLRXUS$36.89M−US$104.2Mn/an/an/a0.3×n/a0.0×1.06
Median of the othersUS$38.06MUS$29.97M33.8×1.8×−557.3%0.0×0.84

Forecasts

Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
5.10 SEK · Analysts' mean
EPS, year to Dec 2026
0.30 · 1 analyst
Revenue, year to Dec 2026
86.8M · 1 analyst

Team and board

OfficerRole
Johan EmilssonCEO
Jenni BjörnulfsonCFO
Lionel TrésauguesDirector of Structure-Based Drug Design

Events

QuarterResultsShare move
Q1 2026May 25, 2026 · Before open+8.3%
Q4 2025Feb 11, 2026 · Before open−9.1%
Q3 2025Nov 25, 2025 · Before open+4.2%
Q2 2025Aug 27, 2025 · Before open−4.4%
Q1 2025May 27, 2025 · Before open0.0%
Q4 2024Feb 12, 2025 · Before open+6.2%
Q3 2024Oct 30, 2024 · Before open−17.4%
Q2 2024Aug 28, 2024 · Before open−3.9%
Q1 2024May 8, 2024 · Before open+0.3%
Q4 2023Feb 14, 2024 · Before open+4.0%
All 20 quarters
QuarterResultsShare move
Q3 2023Oct 25, 2023 · Before open+9.2%
Q2 2023Aug 24, 2023 · Before open+5.9%
Q1 2023May 10, 2023 · Before open+0.9%
Q4 2022Feb 15, 2023 · Before open−0.7%
Q3 2022Oct 26, 2022 · After close
Q2 2022Aug 24, 2022 · After close+3.6%
Q1 2022May 11, 2022 · After close+1.7%
Q4 2021Feb 16, 2022 · Before open−1.8%
Q3 2021Oct 27, 2021 · Before open−1.7%
Quarter to Jun 30, 2021Aug 13, 2021 · Before open−1.4%

Open Events

Decks

DeckKindSlidesDate
Fact Sheet (April 2025)Fact sheet7 slidesApr 24, 2025

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue167.2M65.6M50.5M83.0K35.1M16.9M33.5M17.9M24.0M35.0M
Cost of revenue69.8M28.3M8.70M61.0M10.4M10.5M8.17M745.0K2.99M418.5K
Gross profit97.3M37.3M41.8M-60.9M24.7M6.43M25.4M17.2M21.0M34.6M
Research and development2.88M
Selling, general and administrative34.1M33.6M26.4M31.4M22.2M21.1M18.3M17.2M13.2M11.1M
Operating income97.3M-19.7M-845.0K-60.9M-25.5M-37.7M-20.4M-22.1M-10.7M4.57M
Depreciation and amortization1.07M958.0K447.0K618.0K590.0K697.0K731.0K704.0K564.0K451.2K
EBITDA98.4M-18.7M-398.0K-60.3M-24.9M-37.0M-19.7M-21.4M-10.1M5.02M
Interest expense6.21M40.0K387.0K42.0K269.0K3.44M1.21M137.0K42.0K84.7K
Income before tax91.7M-18.3M-438.0K-60.2M-25.1M-42.8M-21.5M-22.2M-10.7M4.54M
Income tax279.1K741.0K269.0K3.44M1.21M7.00K-292.0K221.7K
Net income91.7M-18.3M-438.0K-60.2M-25.4M-46.2M-22.7M-22.2M-10.7M4.54M
Earnings per share, basic0.99-0.26-0.01-1.43-0.73-2.23-1.51-1.88-1.090.50

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents126.7M25.1M49.9M29.5M70.6M27.1M8.38M14.7M1.48M23.6M
Receivables6.17M12.2M7.94M3.38M2.99M2.79M5.28M219.0K2.69M1.87M
Inventory-7.14M-1.00K11.91M1-219.0K-692.0K-2.67M
Current assets132.9M37.2M57.9M34.9M75.9M32.3M17.4M18.3M4.88M26.9M
Property, plant and equipment3.74M4.72M4.38M2.37M2.99M872.0K1.57M2.21M1.51M1.87M
Total assets136.7M42.1M62.4M37.4M79.1M33.4M19.2M59.3M35.5M49.5M
Accounts payable4.40M5.44M5.71M3.73M2.92M3.40M2.59M4.71M3.39M3.62M
Current liabilities17.5M32.8M34.6M9.23M8.68M24.3M8.23M22.0M7.40M21.0M
Long-term debt00
Total debt10.0M12.0M769.2K
Total liabilities17.5M32.8M34.6M9.23M8.68M24.3M8.23M22.0M7.40M21.0M
Shareholders' equity119.2M9.27M27.8M28.2M70.5M9.14M11.0M37.2M28.1M28.5M
Shares outstanding92.6M69.8M69.8M42.1M34.7M20.7M15.0M11.8M9.81M9.12M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations83.5M-23.4M22.9M-59.1M-40.1M-32.2M-28.0M-19.1M-23.1M7.93M
Capital spending-94.0K-1.30M-2.45M-2.00K-2.71M-2.71M-93.0K-11.1M-8.56M-9.91M
Free cash flow83.4M-24.7M20.4M-59.1M-42.8M-32.2M-28.1M-30.2M-31.6M-1.97M
Cash from investing-54.0K-1.30M-2.45M0-2.71M-2.71M-389.0K-11.1M-8.56M-9.91M
Cash from financing18.2M-225.0K24.0K17.9M86.4M50.9M22.1M43.4M9.49M17.8M
Share buybacks18.2M-225.0K24.0K17.9M88.8M48.9M36.2M37.9M10.3M18.6M
Change in cash101.6M-24.9M20.4M-41.2M43.6M18.7M-6.31M13.2M-22.1M16.0M

Open Financials

Cap table

Built by 6ix from Sprint Bioscience AB’s releases

Common shares
105,515,538
Fully diluted
105,515,538

Fully diluted

LineShares
Common shares105,515,538

Share count over time

CountShares
Nov 22, 2026105,515,538

Open Cap table

Shareholders

Funds

HolderSharesValueAs of
iShares International Small-Cap Equity Factor ETF197KUS$74,639Jul 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Björn Sjöstrand
Chairman of the Board of Directors
Buy30,000SEK 1.45SEK 43,500Dec 10, 2025
Johan Emilsson
Chief Executive Officer (CEO)/Managing Directory
Buy23,750SEK 1.64SEK 38,962Dec 1, 2025
Björn Sjöstrand
Chairman of the Board of Directors
Buy24,872SEK 1.60SEK 39,770Nov 28, 2025
Björn Sjöstrand
Chairman of the Board of Directors
Buy35,108SEK 1.58SEK 55,593Nov 28, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jenni BjörnulfsonCFO · Since at least Apr 1, 2026
Johan EmilssonCEO · Since at least Jul 23, 2026

Open People

Log in to ask 6ix AI your own questions about Sprint Bioscience AB.